Ability Biomedical Corp

Ability Biomedical Corporation discovers and develops fully human antibody therapeutics for cancer and autoimmune diseases in the biotechnology industry. The Company advances preclinical and clinical-stage biotherapeutic candidates and applies generative AI to antibody engineering. Ability Biomedical Corp serves patients with unmet medical needs in the United States and Canada.